A psychotropic drug alters behavior, mood, thoughts, or perception. It’s a blanket term for various drugs, including prescription drugs and commonly misused drugs.
Psychotropic Drugs Market: Introduction
- A psychotropic drug alters behavior, mood, thoughts, or perception. It’s a blanket term for various drugs, including prescription drugs and commonly misused drugs.
- Psychotropic medication are used to treat an assortment of mental health issues when they cause significant hindrance to the healthy functioning of the body
Read Report Overview - https://www.transparencymarketresearch.com/psychotropic-drugs-market.html
- Psychotropic drugs normally work by changing or adjusting the amount of significant chemicals in the brain called neurotransmitters. Some psychological issues show improvement when the level of neurotransmitters, (dopamine, serotonin, and norepinephrine) increases or decreases.
- Psychotropic drugs are typically prescribed by a psychiatrist, a psychiatric nurse practitioner (PMHNP), or a primary care physician; in some areas, clinical psychologists may have prescriptive benefits as well.
Key Drivers and Restraints of Global Psychotropic Drugs Market
- According to a study published in Our World in Data, approximately 970 million people, globally, lived with a mental health disorder in 2018. This is marginally more than one in ten people, globally (10.7%). Increase in population suffering with psychological disorders is projected to fuel the global market during the forecast period.
- According to the World Health Organization (WHO), the population of people aged 60 years and above is projected to rise from 900 million in 2015 to 2 billion in 2050. Usually, the geriatric population is at high risk of mental disorders. Hence, increase in geriatric population is anticipated to boost the global psychotropic drug market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79453
- Government bodies and other public organizations are running programs to raise awareness about mental health. Furthermore, key players or manufacturers are actively focusing on the research and development of new psychological drugs for treatment in an effective and safe manner.
- According to World Health Organization (WHO), nearly two-thirds of people with a known mental disorder never seek help from a health professional. Stigma, discrimination, and neglect prevent care and treatment from reaching people with mental disorders. This is estimated to restrain the psychotropic drugs market in the near future.
Request for Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79453
North America to Dominate Market
- In terms of region, the global psychotropic drug market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- According to the National Council for Behavioral Health, almost half of adults (46.4 percent) are likely to experience a mental health issue during their lifetime in the U.S. Hence, North America is projected to account for a prominent share of the global psychotropic drugs market.
- Europe was the second-largest market for psychotropic drugs, globally, in 2019 due to the presence of favorable reimbursement policies for drugs in most countries across Europe
- The market in Asia Pacific is projected to expand at a notable CAGR, owing to initiatives take by governments in the region toward raising awareness about mental health and the high rate of adoption of psychotropic drugs in the region. This is expected to boost the psychotropic drugs market in Asia Pacific.
- Middle East & Africa is a relatively less lucrative market for psychotropic drugs, globally, due to less or no access available to the target population suffering from mental illness
Pre Book Psychotropic Drugs Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=79453<ype=S
Key Manufacturers Operating in Global Psychotropic Drugs Market
Key manufacturers operating in the global market include:
- Alkermes
- Eli Lilly and Company
- Janssen Global Services, LLC (Johnson & Johnson)
- Allergan (AbbVie Inc.)
- Pfizer Inc.
- Mylan N.V.
- Novartis AG
- Axsome Therapeutics, Inc.
- Acadia Pharmaceuticals Inc.
- Takeda Pharmaceutical Company Limited
Browse More Trending Reports by Transparency Market Research:
Chronic Venous Occlusions Treatment Market: https://www.transparencymarketresearch.com/chronic-venous-occlusions-treatment-market.html
Specialty Generics Market: https://www.transparencymarketresearch.com/specialty-generics-market.html
Clinical Chairs Market: https://www.transparencymarketresearch.com/clinical-chairs-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/